loadpatents
Patent applications and USPTO patent grants for Blanda; Wendy M..The latest application filed is for "sustained action formulation of cyclosporin form 2".
Patent | Date |
---|---|
Sustained Action Formulation Of Cyclosporin Form 2 App 20210236590 - Blanda; Wendy M. ;   et al. | 2021-08-05 |
Biodegradable Intravitreal Tyrosine Kinase Implants App 20210121397 - EDELMAN; Jeffrey L. ;   et al. | 2021-04-29 |
Ocular Implant Made By A Double Extrusion Proces App 20210113592 - Shiah; Jane-Guo ;   et al. | 2021-04-22 |
Biodegradable intravitreal tyrosine kinase implants Grant 10,881,608 - Edelman , et al. January 5, 2 | 2021-01-05 |
Joint fat pad formulations, and methods of use thereof Grant 10,869,955 - Jiang , et al. December 22, 2 | 2020-12-22 |
Dermal filler Grant 10,792,345 - Tezel , et al. October 6, 2 | 2020-10-06 |
Ocular implant made by a double extrusion process Grant 10,702,539 - Shiah , et al. | 2020-07-07 |
Method For Treating Atrophic Age Related Macular Degeneration App 20190336441 - Whitcup; Scott M. ;   et al. | 2019-11-07 |
Method for treating atrophic age related macular degeneration Grant 10,363,214 - Whitcup , et al. | 2019-07-30 |
Biodegradable Intravitreal Tyrosine Kinase Implants App 20190038551 - Edelman; Jeffrey L. ;   et al. | 2019-02-07 |
Ocular Implant Made By A Double Extrusion Proces App 20190015425 - Shiah; Jane-Guo ;   et al. | 2019-01-17 |
Biodegradable intravitreal tyrosine kinase implants Grant 10,076,492 - Edelman , et al. September 18, 2 | 2018-09-18 |
Ocular implant made by a double extrusion process Grant 10,076,526 - Shiah , et al. September 18, 2 | 2018-09-18 |
Autoclavable Suspensions Of Cyclosporin A Form 2 App 20180207230 - Blanda; Wendy M. ;   et al. | 2018-07-26 |
Autoclavable suspensions of cyclosporin A Form 2 Grant 9,919,028 - Blanda , et al. March 20, 2 | 2018-03-20 |
Joint Fat Pad Formulations, And Methods Of Use Thereof App 20170368236 - Jiang; Guang-Liang ;   et al. | 2017-12-28 |
Dermal Filler App 20170216414 - Tezel; Ahmet ;   et al. | 2017-08-03 |
Dermal filler Grant 9,622,957 - Tezel , et al. April 18, 2 | 2017-04-18 |
Autoclavable Suspensions Of Cyclosporin A Form 2 App 20160271207 - Blanda; Wendy M. ;   et al. | 2016-09-22 |
Steroid-containing Sustained Release Intraocular Implants And Related Methods App 20160243032 - Huang; Glenn T. ;   et al. | 2016-08-25 |
Biodegradable Intravitreal Tyrosine Kinase Implants App 20160199297 - Edelman; Jeffrey L. ;   et al. | 2016-07-14 |
Steroid-containing sustained release intraocular implants and related methods Grant 9,327,059 - Huang , et al. May 3, 2 | 2016-05-03 |
Ocular Implant Made By A Double Extrusion Proces App 20160074418 - Shiah; Jane-Guo ;   et al. | 2016-03-17 |
Dermal Filler App 20160038396 - Tezel; Ahmet ;   et al. | 2016-02-11 |
Biodegradable intravitreal tyrosine kinase implants Grant 9,233,070 - Edelman , et al. January 12, 2 | 2016-01-12 |
Ocular implant made by a double extrusion process Grant 9,192,511 - Shiah , et al. November 24, 2 | 2015-11-24 |
Dermal filler Grant 9,161,970 - Tezel , et al. October 20, 2 | 2015-10-20 |
Botulinum toxin formulation Grant 9,050,336 - Blanda , et al. June 9, 2 | 2015-06-09 |
Botulinum toxin formulation Grant 9,044,477 - Blanda , et al. June 2, 2 | 2015-06-02 |
Intraocular Formulation App 20150147406 - Robinson; Michael R. ;   et al. | 2015-05-28 |
Methods Of Treatment Of Ocular Conditions With A Sustained Drug Delivery Implant App 20150140062 - Shiah; Jane-Guo ;   et al. | 2015-05-21 |
Intraocular drug delivery systems Grant 8,969,415 - Robinson , et al. March 3, 2 | 2015-03-03 |
Intraocular Drug Delivery Systems App 20140341968 - Robinson; Michael R. ;   et al. | 2014-11-20 |
Steroid-containing Sustained Release Intraocular Implants And Related Methods App 20140322295 - Huang; Glenn T. ;   et al. | 2014-10-30 |
Method For Treating Atrophic Age Related Macular Degeneration App 20140322206 - Whitcup; Scott M. ;   et al. | 2014-10-30 |
Botulinum Toxin Formulation App 20140302007 - Blanda; Wendy M. ;   et al. | 2014-10-09 |
Sustained Action Formulation Of Cyclosporin Form 2 App 20140296158 - Blanda; Wendy M. ;   et al. | 2014-10-02 |
Method for treating atrophic age related macular degeneration Grant 8,821,870 - Robinson , et al. September 2, 2 | 2014-09-02 |
Sustained action formulation of cyclosporin form 2 Grant 8,785,394 - Blanda , et al. July 22, 2 | 2014-07-22 |
Ocular implant made by a double extrusion process Grant 8,778,381 - Shiah , et al. July 15, 2 | 2014-07-15 |
Methods of treating ocular disease using steroid-containing sustained release intraocular implants Grant 8,771,722 - Huang , et al. July 8, 2 | 2014-07-08 |
Alpha-2 Agonist Polymeric Drug Delivery Systems App 20140038972 - Chang; James N. ;   et al. | 2014-02-06 |
Biodegradable Intravitreal Tyrosine Kinase Implants App 20140031408 - Edelman; Jeffrey L. ;   et al. | 2014-01-30 |
Ocular Implant Made By A Double Extrusion Proces App 20130295157 - Shiah; Jane-Guo ;   et al. | 2013-11-07 |
Valproic Acid Drug Delivery Systems And Intraocular Therapeutic Uses Thereof App 20130237602 - Blanda; Wendy M. ;   et al. | 2013-09-12 |
Alpha-2 agonist polymeric drug delivery systems Grant 8,529,927 - Chang , et al. September 10, 2 | 2013-09-10 |
Ocular Implant Made By A Double Extrusion Process App 20130231318 - Shiah; Jane-Guo ;   et al. | 2013-09-05 |
Biodegradable intravitreal tyrosine kinase implants Grant 8,512,738 - Edelman , et al. August 20, 2 | 2013-08-20 |
Ocular implant made by a double extrusion process Grant 8,506,987 - Shiah , et al. August 13, 2 | 2013-08-13 |
Sustained Action Formulation Of Cyclosporin Form 2 App 20130123195 - Blanda; Wendy M. ;   et al. | 2013-05-16 |
Autoclavable Suspensions Of Cyclosporin A Form 2 App 20130123194 - Blanda; Wendy M. ;   et al. | 2013-05-16 |
Pharmaceutical Formulations and Methods for Treating Ocular Conditions App 20130040895 - Robinson; Michael R. ;   et al. | 2013-02-14 |
Ocular implant made by a double extrusion process Grant 8,318,070 - Shiah , et al. November 27, 2 | 2012-11-27 |
Steroid-containing sustained release intraocular implants and related methods Grant 8,257,730 - Huang , et al. September 4, 2 | 2012-09-04 |
Botulinum Toxin Formulation App 20120141532 - Blanda; Wendy M. ;   et al. | 2012-06-07 |
Steroid-containing Sustained Release Intraocular Implants And Related Methods App 20120122821 - Huang; Glenn T. ;   et al. | 2012-05-17 |
Steroid-containing sustained release intraocular implants and related methods Grant 8,147,865 - Huang , et al. April 3, 2 | 2012-04-03 |
Valproic Acid Drug Delivery Systems And Intraocular Therapeutic Uses Thereof App 20120059060 - Blanda; Wendy M. ;   et al. | 2012-03-08 |
Ocular Implant Made By A Double Extrusion Process App 20110309546 - Shiah; Jane-Guo ;   et al. | 2011-12-22 |
Ocular Implant Made By A Double Extrusion Process App 20110305743 - SHIAH; Jane-Guo ;   et al. | 2011-12-15 |
Ocular implant made by a double extrusion process Grant 8,048,445 - Shiah , et al. November 1, 2 | 2011-11-01 |
Ocular implant made by a double extrusion process Grant 8,034,370 - Shiah , et al. October 11, 2 | 2011-10-11 |
Ocular implant made by a double extrusion process Grant 8,034,366 - Shiah , et al. October 11, 2 | 2011-10-11 |
Valproic Acid Drug Delivery Systems And Intraocular Therapeutic Uses Thereof App 20100204325 - Blanda; Wendy M. ;   et al. | 2010-08-12 |
Kinase inhibitors Grant 7,749,530 - Spada , et al. July 6, 2 | 2010-07-06 |
Drug Delivery Systems And Methods For Treating Neovascularization App 20100098772 - ROBINSON; Michael R. ;   et al. | 2010-04-22 |
Intraocular Formulation App 20100074957 - ROBINSON; MICHAEL R. ;   et al. | 2010-03-25 |
Method For Treating Atrophic Age Related Macular Degeneration App 20100015158 - ROBINSON; Michael R. ;   et al. | 2010-01-21 |
Kinase inhibitors App 20090208557 - Spada; Lon T. ;   et al. | 2009-08-20 |
Stabilization Of Mitochondrial Membranes In Ocular Diseases And Conditions App 20090196905 - Spada; Lon T. ;   et al. | 2009-08-06 |
Dermal filler App 20090155314 - Tezel; Ahmet ;   et al. | 2009-06-18 |
Intraocular Formulation App 20090148527 - Robinson; Michael R. ;   et al. | 2009-06-11 |
Pharmaceutical Formulations And Methods For Treating Ocular Conditions App 20090081277 - Robinson; Michael R. ;   et al. | 2009-03-26 |
Ocular Implant Made By A Double Extrusion Process App 20080286336 - SHIAH; Jane-Guo ;   et al. | 2008-11-20 |
Ocular Implant Made By A Double Extrusion Process App 20080286334 - Shiah; JaneGuo ;   et al. | 2008-11-20 |
Memantine Intravitreal Implants App 20080193502 - HUGHES; PATRICK M. ;   et al. | 2008-08-14 |
Memantine Intravitreal Implants App 20080193503 - HUGHES; PATRICK M. ;   et al. | 2008-08-14 |
Methods For Reducing Neovascularization Or Edema App 20080145407 - Huang; Glenn T. ;   et al. | 2008-06-19 |
Intraocular Drug Delivery Systems App 20080131484 - Robinson; Michael R. ;   et al. | 2008-06-05 |
Ocular Implant Made By A Double Extrusion Process App 20080107712 - Shiah; Jane-Guo ;   et al. | 2008-05-08 |
Anti-angiogenic sustained release intraocular implants and related methods App 20070059336 - Hughes; Patrick M. ;   et al. | 2007-03-15 |
Steroid-containing sustained release intraocular implants and related methods App 20070031472 - Huang; Glenn T. ;   et al. | 2007-02-08 |
Alpha-2 agonist polymeric drug delivery systems App 20060233860 - Chang; James N. ;   et al. | 2006-10-19 |
Sustained release intraocular drug delivery systems App 20060182783 - Hughes; Patrick M. ;   et al. | 2006-08-17 |
Macromolecule-containing sustained release intraocular implants and related methods App 20050281861 - Hughes, Patrick M. ;   et al. | 2005-12-22 |
Memantine intravitreal implants App 20050244473 - Hughes, Patrick M. ;   et al. | 2005-11-03 |
Biodegradable intravitreal tyrosine kinase implants App 20050244475 - Edelman, Jeffrey L. ;   et al. | 2005-11-03 |
Steroid-containing sustained release intraocular implants and related methods App 20050244474 - Huang, Glenn T. ;   et al. | 2005-11-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.